TRPC3 and gastric cancer: The pharmacological blockage of the TRPC3 through inhibition and CRISPR mediated TRPC3 knockout (the technology that can be used to edit genes and known as the clustered regularly interspaced short palindromic repeats) helped pause the overgrowth of gastric cancer in both in vitro and in vivo models (Lin et al., 2021).